Body Weight, the Tumor Necrosis Factor System, and Leptin Production during Treatment with Mirtazapine or Venlafaxine
The DOI matches its Crossref record.
Abstract
Weight gain is a frequent and important side effect of psychopharmacotherapy. Recent studies suggest that the fat-cell-derived hormone leptin and the tumor necrosis factor-alpha (TNF-alpha) cytokine system are pathophysiologically involved. No information is available concerning the influence of the antidepressants mirtazapine and venlafaxine on these immunoendocrine variables. An open-labeled study was performed in 20 patients suffering from major depression treated with either mirtazapine (N = 11) or venlafaxine (N = 9). During 4 weeks, the patients' weight, body mass index (BMI), and plasma levels of leptin, TNF-alpha, sTNF-R p55, and sTNF-R p75 were assessed. Mirtazapine induced a significant increase in weight (mean weight gain: 2.4 kg) that was evident after the first week of treatment. In parallel, the plasma levels of TNF-alpha and both soluble TNF receptors increased. In addition, a slight rise in leptin levels, which occurred slowly and was significant only at the end of the 4 th week of treatment, was observed. Weight decreased slightly but significantly in patients treated with venlafaxine (mean weight loss: 0.4 kg), whereas plasma levels of leptin, TNF-alpha, or soluble TNF receptors did not change significantly. The present results further support the notion that the activation of the TNF-alpha cytokine system is an early, sensitive, and specific marker of weight gain induced by psychotropic agents. In contrast, the effects of such drugs on leptin production seem to be less sensitive with respect to weight gain and more variable.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas, mirtazapine induced a significant increase in the plasma levels of TNF-α and both soluble TNF receptors, venlafaxine did not alter plasma levels of TNF-α, or soluble TNF receptors significantly (201).”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [201]
Citations
Cites
Still being checked.
Cited by
Items 101–143 of 143
Gewichtszunahme unter Psychopharmakotherapie
Himmerich, H., Schuld, A., & Pollmächer, T. (2005) · Max Planck Institute for Plasma Physics · Cited by 9
Self-citationAgrawal, P., Singh, P., & Singh, K. P. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.10.012 · Cited by 8
Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression
Gartlehner, G., Hansen, R. A., Morgan, L. C., Thaler, K. J., Lux, L. J., Noord, M. V., Mager, U., Gaynes, B. N., Thieda, P., Strobelberger, M., et al. (2011) · Cited by 8
Ress, C., Tschoner, A., Kaser, S., & Ebenbichler, C. F. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0004-9 · Cited by 8
Su, J., & Tsang, H. (2006) · PubMed · Cited by 8
Bízik, G., Bob, P., Raboch, J., Pavlat, Uhrová, J., Benaková, H., & Zima, T. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s50197 · Cited by 12
Implications for body weight extremes in solid organ transplantation
Campara, M., Lourenço, L. M., Melaragno, J. I., & Kaiser, T. E. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2493 · Cited by 6
Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men
Lechner, K., Heel, S., Uhr, M., Dose, T., Holsboer, F., Lucae, S., Schaaf, L., Fulda, S., Kloiber, S. M., & Hennings, J. M. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02448-y · Cited by 8
No significant effect of acute moderate alcohol intake on leptin levels in healthy male volunteers
Dammann, G., Dierkes, J., Graf, M., Wiesbeck, G. A., Pridzun, L., Schulte, T., Westphal, S., Luley, C. H., Allen, J., & Wurst, F. M. (2005) · Addiction Biology · doi:10.1080/13556210500313875 · Cited by 6
Psychotropic-Induced Weight Gain: Liability, Mechanisms and Treatment Approaches
McIntyre, R. S., Konarski, J. Z., & Keck, P. E. (2006) · CRC Press eBooks · doi:10.3109/9780849374517.014 · Cited by 6
Gebhardt, S., Heiser, P., Fischer, S., Schneyer, T., Krieg, J.-C., & Vedder, H. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.002 · Cited by 5
Atypische Neuroleptika und metabolisches Syndrom
Baranyi, A., Yazdani, R., Haas-Krammer, A., Stepan, A., Kapfhammer, H., & Rothenhäusler, H. (2007) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-007-0379-9 · Cited by 6
Davis, M. P. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_102-1 · Cited by 5
Affections métaboliques et psychiatrie
Duval, F. (2013) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(13)60022-x · Cited by 4
Immunodepressed Status of Mice after Bulbectomy
Novoselova, E. G., Бобкова, Н. В., Glushkova, O. V., Sinotova, O. A., Ogay, V. B., Medvinskaya, N. I., & Samokhin, A. N. (2004) · Biology Bulletin · doi:10.1023/b:bibu.0000049734.07925.d8 · Cited by 4
Orexigenic Agents in Geriatric Clinical Practice
Viswambharan, V., Manepalli, J. N., & Grossberg, G. T. (2013) · Aging Health · doi:10.2217/ahe.12.83 · Cited by 4
Adverse Effects of Pharmacological Treatments of Major Depression in Older Adults
Sobieraj, D. M. (2019) · doi:10.23970/ahrqepccer215 · Cited by 4
Effect of Antidepressants on Non-alcoholic Fatty Liver Disease and their Underlying Mechanism
Peng, H., Qing, Y., Han, L., Fu, S., Li, J., Wang, S., Liu, D., Liu, L., & Tan, Y. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673317281240828170031 · Cited by 2
An Emerging Role of Leptin in Clinical Psychiatry
Pollmächer, T. (2002) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-642-18999-9_11 · Cited by 2
Self-citationDifferentiation between free and bound leptin in depressed patients
Strauß, M., Mergl, R., Kratzsch, J., Brügel, M., Strauss, E., Hegerl, U., & Schoenknecht, P. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.05.030 · Cited by 2
Hinze‐Selch, D., Däubener, W., Eggert, L., Erdag, S., Stoltenberg, R., & Wilms, S. (2007) · Pharmacopsychiatry · doi:10.1055/s-2007-991756 · Cited by 2
Self-citationHimmerich, H. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_16 · Cited by 2
Metabolic Effects of Two Different Doses of Venlafaxine Therapy on Rats
Annamária, I., Kolcsár, M., Groșan, A., Imre, M., & Dogaru, M. T. (2015) · Acta Marisiensis. Seria Medica · doi:10.1515/amma-2015-0049 · Cited by 1
Medical Management of Obesity Associated with Mood Disorders
McElroy, S. L., Kotwal, R., & Keck, P. E. (2006) · CRC Press eBooks · doi:10.3109/9780849374517.016 · Cited by 1
PSYCHIATRIC MEDICATIONS AND METABOLIC SYNDROME
Mendelson, S. D. (2008) · Elsevier eBooks · doi:10.1016/b978-012374240-7.50007-3 · Cited by 1
McElroy, S. L., Kotwal, R., Nelson, E. B., Malhotra, S., Keck, P. E., & Nemeroff, C. B. (2006) · CRC Press eBooks · doi:10.3109/9780849374517-5 · Cited by 2
5-HT2A a serotonin receptor with a possible role in joint diseases
Kling, A. (2013) · DiVA at Umeå University (Umeå University) · Cited by 2
Mirtazapine‐Associated Rapid Weight Gain and Decreased Physical Activity
Kethini, T., Alderman, C. P., & Doecke, C. J. (2004) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr2004344308 · Cited by 1
Khoza, S. (2011) · Texas ScholarWorks (Texas Digital Library) · Cited by 2
Metabolic alterations in patients with self-inflicted aggressive behaviour
Westling, S. (2009) · Lund University Publications (Lund University)
Swtye, M. H. (2009) · Europe PMC (PubMed Central)
Rapporti tra spettro bipolare, disturbi della condotta alimentare e obesità
Passino, C. S., & Perugi, G. (2005) · CINECA IRIS Institutial research information system (University of Pisa) · Cited by 1
Einfluss von Antidepressiva auf die Zytokinproduktion depressiver Patienten in-vitro
Munzer, A. (2014) · Qucosa (Saxon State and University Library Dresden)
Mirtazapine Review of its Use in Major Depression and Other
Kluwer, W., Anghelescu, I. G., Ishigooka, J., Kasper, S. F., Suzuki, T., & Uchida, H. (2009)
Gangavaram, N. K. R., Siddappa, A. L., Muthiah, B., & Ram, D. (2018) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20180283
Does Inflammation Link Clinical Depression and Coronary Artery Disease?
Jörgens, S., & Arolt, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00022-2
Medikamenteninduzierte Störungen des Glukosestoffwechsels
Kaser, S., & Ress, C. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Current Awareness in Human Psychopharmacology
(2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.460
McElroy, S. L., Kotwal, R., Nelson, E. B., Malhotra, S., Keck, P. E., & Nemeroff, C. B. (2006) · Medical psychiatry · doi:10.3109/9780849374517.003
Himmerich, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_42
Davis, M. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_102
Almeida, O. L. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-03022023-105137
Vedrines, C. O., Hoertel, N., Lesuffleur, T., Denis, P., Olfson, M., Blanco, C., Limosin, F., Rachas, A., Tuppin, P., & Lemogne, C. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121154
Metadata
- Authors
- Kraus, T., Haack, M., Schuld, A., Hinze-Selch, D., Koethe, D., & Pollmächer, T.
- Affiliations
- Max Planck Society (DE)
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 2002-11
- Volume
- 35
- Issue
- 6
- Pages
- 220-225
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2002470967
- Cited by
- 144
- References
- 0
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 5 · 2014: 11 · 2013: 10 · 2012: 8
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacopsychiatry (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- mirtazapine, venlafaxine, antidepressant-induced weight gain, major depressive disorder, leptin, TNF-α, soluble TNF receptors, body weight, body mass index, psychotropic medication side effects
- MeSH terms
- Venlafaxine Hydrochloride, Mirtazapine, Adult, Aged, Body Weight, Cyclohexanols, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, Longitudinal Studies, Male, Mianserin, Middle Aged, Antipsychotic Agents, Tumor Necrosis Factor-alpha, Body Mass Index, Cross-Over Studies, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.